The FDA is recalling nearly 90,000 bottles of children's ibuprofen medication across the United States.

The US Food and Drug Administration recently announced a recall of nearly 90,000 bottles of children's ibuprofen distributed nationwide in the United States, due to consumer complaints of foreign objects in the medication. According to the recall report released by the FDA, this batch of medication was manufactured in India by the international pharmaceutical company Progress Pharma, based in Bangalore, and marketed under the brand "Children's Ibuprofen Oral Suspension" by Taro Pharmaceuticals. Each 5 milliliters of the suspension contains 100 milligrams of ibuprofen, with a bottle capacity of 120 milliliters. The recall involves a total of 89,592 bottles, with an expiration date of January 31, 2027.